Login / Signup

Gadolinium-Based Contrast Agents in Kidney Disease: A Comprehensive Review and Clinical Practice Guideline Issued by the Canadian Association of Radiologists.

Nicola SchiedaJason I BlaichmanAndreu F CostaRafael GliksteinCasey D HurrellMatthew JamesPejman Jabehdar MaralaniWael ShabanaAn TangAnne TsampalierosChristian B van der PolSwapnil Hiremath
Published in: Canadian journal of kidney health and disease (2018)
In patients with AKI and category G4 and G5 CKD (eGFR < 30 mL/min/1.73 m2) and in dialysis-dependent patients who require GBCA-enhanced MRI, GBCA can be administered with exceedingly low risk of causing NSF when using macrocyclic agents and newer linear agents at routine doses.
Keyphrases